Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer

Basit Öğe Kaydı
dc.authorscopusid31767766600en_US
dc.authorwosidCDM-6595-2022en_US
dc.contributor.authorOktay, Kutluk H.
dc.contributor.authorTuran, Volkan
dc.contributor.authorBedoschi, Giuliano
dc.contributor.authorGoldfarb, Shari
dc.contributor.authorBang, Heejung
dc.date.accessioned2023-03-16T07:18:59Z
dc.date.available2023-03-16T07:18:59Z
dc.date.issued2023en_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalıen_US
dc.description.abstractThe likelihood of post-chemotherapy (ChT) amenorrhea is still empirically determined. Breast cancer is the most prevalent malignancy among the women of reproductive age. Our aim was to determine the predictors of amenorrhea risk post-ChT in women with breast cancer (ca). As acute amenorrhea (<12mo post-ChT) can be temporary, we used amenorrhea status 12- and 18-months post-ChT as the primary endpoint.en_US
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA -- R01HD053112en_US
dc.identifier.citationOktay, K. H., Turan, V., Bedoschi, G., Goldfarb, S., & Bang, H. (2023). Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer. Fertility and Sterility, 118(4), pp. E231-E231.en_US
dc.identifier.endpageE231en_US
dc.identifier.issn0015-0282
dc.identifier.issn1556-5653
dc.identifier.issue4en_US
dc.identifier.startpageE231en_US
dc.identifier.urihttps://hdl.handle.net/20.500.13055/417
dc.identifier.volume118en_US
dc.identifier.wosWOS:000891804600558en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynak.otherSCI-E - Science Citation Index Expandeden_US
dc.institutionauthorTuran, Volkan
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofFertility and Sterilityen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBrca Mutationsen_US
dc.subjectBreast Canceren_US
dc.subjectPre-Chemotherapyen_US
dc.subjectAMH Levelen_US
dc.titlePresence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast canceren_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
Presence of BRCA mutations and a pre_chemotherapy AMH level of 2NG_ML strongly predict risk of amenorrhea in women with breast cancer.pdf
Boyut:
150.92 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Cerrahi Tıp Bilimleri Bölümü Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu